Severe Hypomagnesemia During Long-term Treatment With a Proton Pump Inhibitor

被引：58
作者：
Regolisti, Giuseppe [1 ]
Cabassi, Aderville [1 ]
Parenti, Elisabetta [1 ]
Maggiore, Umberto [1 ]
Fiaccadori, Enrico [1 ]
机构：
[1] Univ Parma, Dipartimento Clin Med Nefrol & Sci Prevenz, I-43100 Parma, Italy
来源：
AMERICAN JOURNAL OF KIDNEY DISEASES | 2010年 / 56卷 / 01期
关键词：
Hypomagnesemia; proton pump inhibitors; BARTTERS-SYNDROME; SENSORINEURAL DEAFNESS; INTENSIVE-CARE; INTESTINAL-ABSORPTION; HYPOKALEMIC ALKALOSIS; MAGNESIUM LOSS; MUTATIONS; GENE; HYPOCALCEMIA; OMEPRAZOLE;
D O I：
10.1053/j.ajkd.2010.03.013
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：168 / 174
页数：7
相关论文
共 50 条
  • [41] Hypomagnesaemia associated with long-term use of proton pump inhibitors
    Toh, James Wei Tatt
    Ong, Evonne
    Wilson, Robert
    GASTROENTEROLOGY REPORT, 2015, 3 (03): : 243 - 253
  • [42] Proton pump inhibitor-induced hypomagnesemia complicated with serious cardiac arrhythmias
    Chrysant, Steven G.
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2019, 17 (05) : 345 - 351
  • [43] A Proton Pump Inhibitor in the Reformulation Setting: Bioequivalence and Potential Implications for Long-Term Safety
    Dubcenco, E.
    Beers-Block, P. M.
    Kim, L. P.
    Schotland, P.
    Levine, J. G.
    McCloskey, C. A.
    Bashaw, E. D.
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2017, 10 (05): : 387 - 394
  • [44] Factors influencing compliance in long-term proton pump inhibitor therapy in general practice
    Hungin, APS
    Rubin, G
    O'Flanagan, H
    BRITISH JOURNAL OF GENERAL PRACTICE, 1999, 49 (443) : 463 - 464
  • [45] Proton Pump Inhibitor Use in Older Adults: Long-Term Risks and Steps for Deprescribing
    Pezeshkian, Sara
    Conway, Susan E.
    CONSULTANT PHARMACIST, 2018, 33 (09): : 497 - 503
  • [46] An approach to the diagnosis and management of a case presenting with recurrent hypomagnesemia secondary to the chronic use of a proton pump inhibitor
    dos Santos, Livia Marcela
    Guerra, Ricardo Ayello
    Lazaretti-Castro, Marise
    Vieira, Jose Gilberto H.
    Portes, Evandro de Souza
    Dias-da-Silva, Magnus R.
    MAGNESIUM RESEARCH, 2015, 28 (04) : 136 - 145
  • [47] Long-term proton pump inhibitor use is a risk factor for mortality in patients hospitalized for COVID-19
    Yozgat, Ahmet
    Kasapoglu, Benan
    Can, Guray
    Tanoglu, Alpaslan
    Sakin, Yusuf Serdar
    Yalcin, Kadir Serkan
    Gurler, Mujgan
    Kaplan, Mustafa
    Kaban, Mehmet Gokturk
    Kirsoy, Mehmet
    Kara, Umut
    Kekilli, Murat
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2021, 51 (04) : 1675 - 1681
  • [48] Long-term Treatment With Proton Pump Inhibitors Is Effective in Children With Eosinophilic Esophagitis
    Gutierrez-Junquera, Carolina
    Fernandez-Fernandez, Sonia
    Luz Cilleruelo, M.
    Rayo, Ana
    Echeverria, Luis
    Borrell, Belen
    Roman, Enriqueta
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2018, 67 (02) : 210 - 216
  • [49] Influence of hypergastrinemia secondary to long-term proton pump inhibitor treatment on ECL cell tumorigenesis in human gastric mucosa
    Tatsuguchi, Atsushi
    Hoshino, Shintaro
    Kawami, Noriyuki
    Gudis, Katya
    Nomura, Tsutomu
    Shimizu, Akira
    Iwakiri, Katsuhiko
    PATHOLOGY RESEARCH AND PRACTICE, 2020, 216 (10)
  • [50] Rebound Acid Hypersecretion after Withdrawal of Long-Term Proton Pump Inhibitor (PPI) Treatment-Are PPIs Addictive?
    Namikawa, Ken
    Bjornsson, Einar Stefan
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (10)
12345